Misplaced Pages

Gilles-Éric Séralini

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Seralini)

Gilles-Éric Séralini
Gilles-Éric Séralini, in 2015
Born (1960-08-23) 23 August 1960 (age 64)
Bône, Algeria (then French Algeria)
Alma materUniversity of Montpellier II
Known forSéralini affair
SpouseSoline Séralini
ChildrenTwo
AwardsKnight of the National Order of Merit, Denis Guichard prize, Theo Colborn Award, whistleblower award, International Scientist of the Year.
Scientific career
FieldsEndocrinology
InstitutionsUniversity of Caen
ThesisRôle inhibiteur de l'alphafoetoprotéine sur la fonction génitale du rat (1987)

Gilles-Éric Séralini (born 23 August 1960) is a French molecular biologist, political advisor and activist on genetically modified organisms and foods. He is of Algerian-French origin. Séralini has been a professor of molecular biology at the University of Caen since 1991, and is president and chairman of the board of CRIIGEN.

His work and publication strategies on GMOs have been controversial. A paper he published in 2012 attracted major controversy and was retracted by the journal.

Early life

Séralini was born on 23 August 1960 in Bône, Algeria, during the Algerian War of Independence. His father was a telecommunications technician and his mother was a schoolteacher. His family soon settled in Thonon-les-Bains, Haute Savoie, and then Nice, France.

Career

In 1987, Séralini obtained his doctoral degree from the University of Montpellier II. He then did four years of research at, among other places, the University of Western Ontario and Laval University Medical Center. Séralini underwent research on corticosteroid-binding globulin, before being appointed a professor at the University of Caen in June 1991, a position he has held ever since. The general area of his lab's research focuses on the endocrine system, in particular the enzyme aromatase. His lab has synthesized a number of aromatase inhibitors using equine aromatase as a model. His research has been published in the Journal of Histochemistry & Cytochemistry, the Journal of Steroid Biochemistry and Molecular Biology, and Molecular and Cellular Endocrinology.

In 1997, he became interested in genetically modified organisms, publicly appealing for the precautionary principle to be followed. He was appointed to various government posts, including roles in the French government, the European Union and the European Commission. From 1998 till 2007 Séralini was a member of the French Biomolecular Engineering Commission which was tasked with evaluating GMO allowances for both the French Ministry of Agriculture and Ministry of the Environment.

CRIIGEN

Séralini founded the Committee of Research and Independent Information on Genetic Engineering (CRIIGEN) with Corine Lepage, a former politician, and Pierre-Henri Gouyon, a professor from the Muséum national d'histoire naturelle, in 1999. CRIIGEN is publicly opposed to genetically modified food (GM food). Séralini founded CRIIGEN because he judged that studies on GM food safety were inadequate, and questioned their acceptance.

In 2007, Séralini and two other authors from the University of Caen and the University of Rouen published a Greenpeace-funded paper using data obtained from rat feeding studies conducted by Monsanto in 2004. They concluded that the genetically modified maize used, MON 863, resulted in significant variations to the control rats weight, triglyceride levels and urine composition. They also concluded it effected the liver, kidney, adrenal glands, heart, and haematopoietic system and recommended that safety experiments continue beyond 90 days. Greenpeace cited the study in a press release calling for MON 863's recall and a review of testing methods.

The paper prompted the European Food Safety Authority (EFSA) to reexamine the MON 863 safety data. It asked EU countries for any new data about the strain, new opinions on the original Monsanto study and a technical meeting with the authors of the 2007 CRIIGEN paper. The EFSA concluded that all blood chemistry and organ weight values fell within the normal range for the control animals in question and that the Séralini paper used incorrect statistical methods. In 2010 Markos Kyprianou (European Commissioner for Health and Consumer Policy) confirmed the doubts in a report to the European Parliament. The French Commission du Génie Biomoléculaire (AFBV) also reached critical conclusions. "Food Standards Australia New Zealand attributed the differences between rats fed MON 863 corn and control rats to normal biological variation (for the species in question)."

In 2009, the Séralini lab published another study, which re-analyzed toxicity data for glyphosate resistant, MON 810 and MON 863 strains, concluded that they showed liver, kidney and heart damages in the rats. EFSA found no base for the claims and saw many of the statistical criticisms of the 2007 paper applying to the 2009 paper also. The French High Council of Biotechnologies Scientific Committee [fr] (HCB) concluded that Séralini 2009 "..presents no admissible scientific element likely to ascribe any haematological, hepatic or renal toxicity to the three re-analysed GMOs." Food Standards Australia New Zealand had a similar result. The HCB also questioned the authors' independence.

A 2011 review by Séralini, using data from 19 published animal feeding studies and several animal feeding studies submitted for regulatory approval, continued to conclude that GM food had liver and kidney effects, and advocated for longer and more elaborate toxicology tests for regulatory approval.

2012 paper

Main article: Séralini affair

On 19 September 2012, Séralini and his colleagues published a peer-reviewed paper funded by CRIIGIN titled "Long-term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize" in Food and Chemical Toxicology (FCT). It involved a two-year study of genetically modified corn and the herbicide RoundUp fed to rats. At a press conference announcing his paper, Séralini emphasized the study's potential cancer implications. Photographs from the journal article of treated rats with large tumors were widely circulated in the press. In November 2013, the FCT editors retracted the paper, with the editor-in-chief saying that its results were inconclusive. In June 2014 the text of the article was republished in Environmental Sciences Europe.

With a few exceptions, the scientific community dismissed the Séralini study and called for a more rigorous peer-review system in scientific journals.

After Séralini published his 2012 corn study in parallel with a book and a documentary called Tous Cobayes !, various French Academies wrote a common bulletin expressing a number of concerns related to the study. The bulletin criticizes the science behind the study, questions the ethics of the study's authors and the standards of the publishing journal (Food and Chemical Toxicology), and states concern over the social consequences of what the bulletin's authors perceive to be scaremongering in the area of GMOs. Signatories of the bulletin included the Académie d'agriculture de France, Académie nationale de médecine, Académie nationale de pharmacie, Académie des sciences, Académie des technologies and Académie vétérinaire de France.

Recent work

In May 2013, shortly before a debate was scheduled to take place on the topic of genetically modified foods, held by the libertarian think tank Cato Institute, both Séralini and consumer activist Jeffrey M. Smith withdrew from the debate. Smith disapproved of the planned inclusion of molecular biologist Kevin Folta and Séralini accused Jon Entine, who organized the debate's panel, of libel.

In 2014, Séralini et al. published a study claiming that pesticides were more toxic than regulatory bodies had previously thought. The study prompted Ralf Reski, one of the editors of BioMed Research International, the journal in which it was published, to resign. Reski said, "I do not want to be connected to a journal that provides a forum for such kind of agitation."

Various journalists criticized Séralini's strategy towards the public, since he asked media to sign non-disclosure agreements before the publishing and tried to interdict requests to other scientists. The publication strategy overall has been deemed flawed and questionable again, as it connected allegedly flawed scientific studies, various publications, books and films in parallel while trying to silence scientific and public debate in a broad political campaign of questionable value.

A 2016 paper published by Seralini claims homeopathic remedies protect against acute glyphosate intake alleged toxicity. This claim is without any scientific basis or evidence. A strong consensus prevails among the scientific community that homeopathy is a pseudo-scientific, unethical and implausible line of treatment.

Supporters and funding

Gilles-Eric Séralini has published various studies and a book Nous pouvons nous dépolluer (We are able to detox ourselves, 2009) claiming certain plant based pharmaceuticals based on homeopathy were being able to decrease poisonous influences. The related lab received funding from Sevene Pharma to study the detoxifying capacity of their plant extracts on Roundup residues, bisphenol A and atrazine. Séralini participated and received payment for a lecture in a two-day seminar organized by Sevene Pharma.

In 2010, Séralini sued University of Paris VII Marc Fellous [fr], president of the French Association of Plant Biotechnology [fr] and the Association, for libel, claiming that they had unjustly criticized his scientific ability and his research because of its funder, Greenpeace. The judge ruled that because Fellous and other critics had financial ties to the agricultural biotechnology industry, their charge about the Greenpeace funding was defamatory, but refused to rule on the scientific matter. Fellous was fined 1000 euros. Séralini was awarded a symbolic 1 euro in damages and court costs.

Awards and honors

  • Chevalier de l'ordre national du Mérite, from the French government, for his whole career in the field of biology.
  • In 2015 Séralini was awarded the "whistleblower" award by the Federation of German Scientists and the German branch of the International Association of Lawyers Against Nuclear Arms ILANA.
  • In January 2002, Gilles-Eric Séralini received the 2001 Denis Guichard Prize "for his work and expertise on GMOs and his activities in favor of an ethical and independent scientific evaluation".
  • In February 2012, Professor Gilles-Eric Séralini was awarded the prize of "International Scientist of the Year 2011", by the Cambridge International Biographical Center, "for his extensive research on the effects of GMOs and pesticides on health ".
  • In March 2016, he received the Theo Colborn Award at the San Diego Symposium on Environmental Health in the United States.

Selected publications

Scientific papers

Books

References

  1. Guilhot, Alain (21 November 2012). "Gilles-Eric Seralini: The man with the rats". Le Monde. Retrieved 3 September 2013.
  2. "Pr. Gilles-Eric Séralini Président du Conseil Scientifique Enseignant Chercheur". CRIIGEN. Archived from the original on 22 December 2015.
  3. ^ Fischer L. "Gentechnik: "Aus nicht haltbaren Versuchen wird eine politische Kampagne"". ZEIT ONLINE. Retrieved 16 December 2015.
  4. Laure Noualhat for Libération. 19 October 2012. Gilles-Eric Séralini. OGM pas du tout. Via Google Translate, English translation
  5. ^ "OGM : Gilles-Éric Séralini, un scientifique engagé et critiqué". Le Monde (in French). 20 September 2012.
  6. Séralini G, Moslemi S (June 2001). "Aromatase inhibitors: past, present and future". Molecular and Cellular Endocrinology. 178 (1–2): 117–31. doi:10.1016/S0303-7207(01)00433-6. PMID 11403901. S2CID 39968497.
  7. Ces OGM qui changent le monde, Flammarion, 2010, quatrième de couverture.
  8. ^ "HH", CRIIGEN, 12 12 November 2008 Profile, Pr Gilles Eric Séralini – President of the Scientific Board – Molecular Biology Professor Archived 30 March 2014 at the Wayback Machine
  9. Carman T (19 September 2012). "French scientists question safety of GM corn". The Washington Post. Retrieved 20 May 2013.
  10. Agence France-Presse. 19 October 2012, as posted on phys.org. Six French academies dismiss study linking GM corn to cancer (Update 2)
  11. ^ Séralini GE, Cellier D, de Vendomois JS (May 2007). "New analysis of a rat feeding study with a genetically modified maize reveals signs of hepatorenal toxicity". Archives of Environmental Contamination and Toxicology. 52 (4): 596–602. Bibcode:2007ArECT..52..596S. doi:10.1007/s00244-006-0149-5. PMID 17356802. S2CID 2521185.
  12. "GM maize MON863: French scientists doubt safety". GMO Compass. 16 March 2007. Archived from the original on 30 December 2010. Retrieved 11 November 2010.
  13. Ananda R (2010). "Three Approved GMOs Linked to Organ Damage" (PDF). Z Magazine. 23 (3). Archived from the original (PDF) on 20 October 2013. The data 'clearly underlines adverse impacts on kidneys and liver, the dietary detoxifying organs, as well as different levels of damages to heart, adrenal glands, spleen, and haematopoietic system,' reported Gilles-Eric Séralini, a molecular biologist at Caen University.
  14. "Regulatory systems for GE crops a failure: the case of MON863" (PDF). Greenpeace. Archived from the original (PDF) on 30 March 2009. Retrieved 21 July 2010. Greenpeace demands an immediate and complete recall of MON863 from the global market. We also call upon governments to undertake an urgent reassessment of all other authorised GE products and a strict review of current testing methods.
  15. Statement of the Scientific Panel on Genetically Modified Organisms on the analysis of data from a 90-day rat feeding study with MON 863 maize "Statement on the analysis of data from a 90-day rat feeding study with MON 863 maize by the Scientific Panel on genetically modified organisms (GMO)". 28 June 2007.
  16. European Food Safety Authority (2007). "EFSA review of statistical analyses conducted for the assessment of the MON 863 90-day rat feeding study". EFSA Journal. 5 (6): 19r. doi:10.2903/j.efsa.2007.19r.
  17. Les experts européens innocentent un OGM Le Figaro, 13 July 2007. Retrieved 27 October 2010 Archived 6 November 2014 at the Wayback Machine
  18. Les Organismes Génétiquement Modifiés, Annexe B. Avis de la commission du génie biomoléculaire sur l’étude statistique du CRIIGEN du maïs MON863 Report prepared for the French Prime Minister by the Centre d'Analyse Strategique, 20 July 2007. Retrieved 31 May 2013 Archived 13 July 2011 at the Wayback Machine
  19. "Review of the report by Séralini et al., (2007): "New analysis of a rat feeding study with a genetically modified maize reveals signs of hepatorenal toxicity"". FSANZ final assessment report. Archived from the original on 16 May 2009. Retrieved 11 November 2010.
  20. "FSANZ reaffirms its risk assessment of genetically modified corn MON 863". FSANZ fact sheets 2007. 25 July 2010. Archived from the original on 16 December 2010. Retrieved 11 November 2010.
  21. de Vendômois JS, Roullier F, Cellier D, Séralini GE (December 2009). "A comparison of the effects of three GM corn varieties on mammalian health". International Journal of Biological Sciences. 5 (7): 706–26. doi:10.7150/ijbs.5.706. PMC 2793308. PMID 20011136.
  22. "EFSA Minutes of the 55th Plenary Meeting of the Scientific Panel on Genetically Modified Organisms Held on 27–28 January 2010 IN Parma, Italy, Annex 1, Vendemois et al 2009" (PDF). European Food Safety Authority report. Retrieved 11 November 2010.
  23. ^ "Opinion relating to the deposition of 15 December 2009 by the Member of Parliament, François Grosdidier, as to the conclusions of the study entitled "A comparison of the effects of three GM corn varieties on mammalian health"". English translation of French High Council of Biotechnologies Scientific Committee document. Archived from the original on 30 October 2012. Retrieved 11 November 2010.
  24. "Feeding studies and GM corn MON863". Food Standards Australia New Zealand. July 2012. Archived from the original on 25 October 2012. Retrieved 10 October 2012.
  25. Séralini, Gilles-Eric; Mesnage, Robin; Clair, Emilie; Gress, Steeve; De Vendômois, Joël; Cellier, Dominique (2011). "Genetically modified crops safety assessments: Present limits and possible improvements". Environmental Sciences Europe. 23: 10. doi:10.1186/2190-4715-23-10.
  26. Vidal J (28 September 2012). "Study linking GM maize to cancer must be taken seriously by regulators". The Guardian. London. Retrieved 8 May 2013.
  27. ^ Butler D (October 2012). "Hyped GM maize study faces growing scrutiny". Nature. 490 (7419): 158. Bibcode:2012Natur.490..158B. doi:10.1038/490158a. PMID 23060167.
  28. "France orders probe after rat study links genetically modified corn to cancer". Agence France-Presse. 20 September 2012. Retrieved 26 December 2015.
  29. "Elsevier Announces Article Retraction from Journal Food and Chemical Toxicology". Elsevier. Retrieved 29 November 2013.
  30. Wallace Hayes A (March 2014). "Editor in Chief of Food and Chemical Toxicology answers questions on retraction". Food and Chemical Toxicology. 65: 394–5. doi:10.1016/j.fct.2014.01.006. PMID 24407018.
  31. Cassasus, Barbara (25 June 2014). "Paper claiming GM link with tumours republished". Nature. Retrieved 31 August 2015.
  32. Martinelli L, Karbarz M, Siipi H (February 2013). "Science, safety, and trust: the case of transgenic food". Croatian Medical Journal. 54 (1): 91–6. doi:10.3325/cmj.2013.54.91. PMC 3584506. PMID 23444254.
  33. Avis du 19 octobre 2012 Avis des Académies nationales d’Agriculture, de Médecine, de Pharmacie, de s Sciences, des Technologies, et Vétérinaire sur la publication récente de G.E. Séra lini et al. sur la toxicité d’un OGM
  34. Entine, Jon (29 May 2013). "Anti-GMO Scientist Gilles-Eric Seralini, Activist Jeffrey Smith Withdraw from Food Biotech Debate". Forbes.com. Retrieved 4 September 2013.
  35. Mesnage R, Defarge N, Spiroux de Vendômois J, Séralini GE (2014). "Major pesticides are more toxic to human cells than their declared active principles". BioMed Research International. 2014: 179691. doi:10.1155/2014/179691. PMC 3955666. PMID 24719846.
  36. Kupferschmidt, Kai (10 February 2014). "Pesticide Study Sparks Backlash". Science Insider. Retrieved 16 March 2014.
  37. Kloor K (26 September 2012). "GMO Opponents Are the Climate Skeptics of the Left". Slate. ISSN 1091-2339. Retrieved 17 December 2015.
  38. "From Darwinius to GMOs: Journalists Should Not Let Themselves Be Played - The Loom". The Loom. Carl Zimmer. 21 September 2012. Archived from the original on 21 September 2012. Retrieved 17 December 2015.
  39. Gress S, Laurant C, Defarge N, Travert C, Séralini GÉ (July 2016). "Dig1 protects against locomotor and biochemical dysfunctions provoked by Roundup". BMC Complementary and Alternative Medicine. 16 (1): 234. doi:10.1186/s12906-016-1226-6. PMC 4957837. PMID 27450510.
  40. Tuomela, R (1987). "Chapter 4: Science, Protoscience, and Pseudoscience". In Pitt JC, Marcello P (eds.). Rational Changes in Science: Essays on Scientific Reasoning. Boston Studies in the Philosophy of Science. Vol. 98. Springer. pp. 83–101. doi:10.1007/978-94-009-3779-6_4. ISBN 978-94-010-8181-8.
  41. Smith K (2012). "Homeopathy is Unscientific and Unethical". Bioethics. 26 (9): 508–12. doi:10.1111/j.1467-8519.2011.01956.x. S2CID 143067523. Archived from the original on 29 October 2017. Retrieved 3 May 2021.
  42. Baran GR, Kiana MF, Samuel SP (2014). "Science, Pseudoscience, and Not Science: How do They Differ?". Healthcare and Biomedical Technology in the 21st Century. Springer. pp. 19–57. doi:10.1007/978-1-4614-8541-4_2. ISBN 978-1-4614-8540-7. within the traditional medical community it is considered to be quackery
  43. Ladyman J (2013). "Chapter 3: Towards a Demarcation of Science from Pseudoscience". In Pigliucci M, Boudry M (eds.). Philosophy of Pseudoscience: Reconsidering the Demarcation Problem. University of Chicago Press. pp. 48–49. ISBN 978-0-226-05196-3. Yet homeopathy is a paradigmatic example of pseudoscience. It is neither simply bad science nor science fraud, but rather profoundly departs from scientific method and theories while being described as scientific by some of its adherents (often sincerely).
  44. Shaw, DM (2010). "Homeopathy is where the harm is: Five unethical effects of funding unscientific 'remedies'". Journal of Medical Ethics. 36 (3): 130–31. doi:10.1136/jme.2009.034959. PMID 20211989.
  45. Sample I (21 July 2008). "Pharmacists urged to 'tell the truth' about homeopathic remedies". The Guardian. London. Archived from the original on 4 May 2021. Retrieved 3 May 2021.
  46. "Homeopathy". American Cancer Society. Archived from the original on 16 March 2013. Retrieved 12 October 2014.
  47. UK Parliamentary Committee Science and Technology Committee - "Evidence Check 2: Homeopathy" Archived 2015-07-26 at the Wayback Machine
  48. Grimes, D.R. (2012). "Proposed mechanisms for homeopathy are physically impossible". Focus on Alternative and Complementary Therapies. 17 (3): 149–55. doi:10.1111/j.2042-7166.2012.01162.x.
  49. "Homeopathic products and practices: assessing the evidence and ensuring consistency in regulating medical claims in the EU" (PDF). European Academies' Science Advisory Council. September 2017. p. 1. Archived (PDF) from the original on 22 September 2017. Retrieved 1 October 2017. ... we agree with previous extensive evaluations concluding that there are no known diseases for which there is robust, reproducible evidence that homeopathy is effective beyond the placebo effect.
  50. Gasnier C, Benachour N, Clair E, Travert C, Langlois F, Laurant C, Decroix-Laporte C, Séralini GE (October 2010). "Dig1 protects against cell death provoked by glyphosate-based herbicides in human liver cell lines". Journal of Occupational Medicine and Toxicology. 5: 29. doi:10.1186/1745-6673-5-29. PMC 2987375. PMID 20979644.
  51. Mesnage R, Defarge N, Rocque LM, Spiroux de Vendômois J, Séralini GE (2 July 2015). "Laboratory Rodent Diets Contain Toxic Levels of Environmental Contaminants: Implications for Regulatory Tests". PLOS ONE. 10 (7): e0128429. Bibcode:2015PLoSO..1028429M. doi:10.1371/journal.pone.0128429. PMC 4489719. PMID 26133768.
  52. Olivier V (19 January 2011). "OGM: deux chercheurs au tribunal" [GMOs: two researchers in court]. L'Express (in French).
  53. JORF No. 0026 du 31 janvier 2008, page 1853, texte No. 14, « décret du 30 janvier 2008 portant promotion et nomination ».
  54. https://www.vdw-ev.de/wp-content/uploads/2016/07/full_reasoning_whistleblower_seralini_en.pdf
  55. "Les lauréats de la Fondation Denis Guichard - Denis Guichard-Un nouveau regard sur le Vivant". Archived from the original on 7 December 2015. Retrieved 7 December 2015.
  56. -le-prix-de-l-ego,771.html "Archived copy". Archived from the original on 18 April 2019. Retrieved 18 April 2019.{{cite web}}: CS1 maint: archived copy as title (link)
  57. "Gilles-Eric Séralini reconnu par ses pairs avec le prix Theo Colborn".
Portals: Categories: